​

Monte Rosa Therapeutics (GLUE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Monte Rosa Therapeutics Revenue Highlights

Latest Revenue (Y)

$75.62M

Latest Revenue (Q)

$4.70M

Monte Rosa Therapeutics Revenue by Period

Monte Rosa Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$75.62M100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Monte Rosa Therapeutics generated $75.62M in revenue during NA 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Monte Rosa Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$4.70M341.26%
2024-03-31$1.06M-87.84%
2023-12-31$8.75M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Monte Rosa Therapeutics generated $4.70M in revenue during Q2 2024, up 341.26% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Monte Rosa Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
GLUEMonte Rosa Therapeutics$75.62M$4.70M
NRIXNurix Therapeutics$54.55M$18.45M
KYMRKymera Therapeutics$47.07M$3.74M
STOKStoke Therapeutics$36.55M$4.89M
FHTXFoghorn Therapeutics$22.60M$7.81M
GBIOGeneration Bio$19.89M$4.09M
STTKShattuck Labs$5.72M$1.61M
HOWLWerewolf Therapeutics$1.89M$1.14M
IKNAIkena Oncology--
DSGNDesign Therapeutics--
SANASana Bio--
NKTXNkarta--
ERASErasca--
LYELLyell Immunopharma-$34.00K

GLUE Revenue FAQ

What is Monte Rosa Therapeutics’s yearly revenue?

Monte Rosa Therapeutics's yearly revenue for 2024 was $75.62M, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. GLUE's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Monte Rosa Therapeutics’s quarterly revenue?

Monte Rosa Therapeutics's quarterly revenue for Q2 2024 was $4.7M, a 341.26% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.06M, a -87.84% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). GLUE's quarterly revenue for Q4 2023 was $8.75M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Monte Rosa Therapeutics’s revenue growth rate?

Monte Rosa Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.